![Tenomix](https://storage.googleapis.com/dealroom-images-production/49/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA2LzI1L2MzZDFhMTc0OTZiZDhkNmEzMmRkZTRhYmFhZmI3MTIx.png)
Tenomix
Verified(Brampton Venture Zone Client) - Tenomix develops novel technologies that target inefficiencies in the pathology workflow, optimize cancer care, and reduce healthcare costs.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$6—9m (Dealroom.co estimates Mar 2024.)
London Ontario (HQ), Brampton Ontario (founding location)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | $0.0 | round |
investor | $0.0 | round | |
N/A | $0.0 | round | |
* | CAD2.0m | Seed | |
Total Funding | 000k |
Related Content
Recent News about Tenomix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.